Continued adjuvant FOLFIRINOX for BRPC or LAPC after neoadjuvant FOLFIRINOX.

Jaewoo ParkHae Young KimHee Young NaJun Suh LeeJong-Chan LeeJin Won KimYoo-Seok YoonJin-Hyeok HwangHo-Seong HanYong-Tae Kim

Published in: Journal of cancer research and clinical oncology (2022)

Continued adjuvant mFOLFIRINOX and post-treatment CA 19-9 level were associated with survival in patients with BRPC or LAPC who received neoadjuvant FOLFIRINOX and surgery. Continued adjuvant mFOLFIRINOX after neoadjuvant FOLFIRINOX could be considered for patients with good performance.

Keyphrases

locally advanced
rectal cancer
early stage
squamous cell carcinoma
radiation therapy
minimally invasive
coronary artery bypass
lymph node